Actinium Pharmaceuticals
ATNM
#9653
Rank
A$66.56 M
Marketcap
$2.13
Share price
-7.19%
Change (1 day)
-84.60%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -A$66.68 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are A$0.08 Million. In 2023 the company made an earning of -A$85.88 Million a decrease over its 2022 earnings that were of -A$56.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$66.68 Million-22.36%
2023 -A$85.88 Million52.24%
2022 -A$56.41 Million36.61%
2021 -A$41.3 Million11.48%
2020 -A$37.04 Million1.46%
2019 -A$36.51 Million-7.37%
2018 -A$39.42 Million-11.46%
2017 -A$44.52 Million10.67%
2016 -A$40.22 Million15.7%
2015 -A$34.77 Million-14.86%
2014 -A$40.84 Million129.19%
2013 -A$17.82 Million-8.55%
2012 -A$19.49 Million
2010 A$0.01 M-152.15%
2009 -A$0.03 Million-39.8%
2008 -A$0.05 Million120.29%
2007 -A$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$61.52 Million-17.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.89 B-1,305.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$47.57 Million-36.04%๐Ÿ‡บ๐Ÿ‡ธ USA